In addition to a heightened risk of pancreatitis and gallstones, Wegovy patients have also suffered from: Severe and Prolonged Vomiting While nausea and some vomiting are normal side effects of Wegovy, some patients experience frequent vomiting that lasts for two weeks or more
Interactions and Special Precautions Oral semaglutide can slow stomach emptying and may affect the absorption of some oral medicines
At present, retatrutide is primarily available within clinical trial settings
Clinical Studies 14.1 Cardiovascular Outcomes Trial in Adult Patients with Cardiovascular Disease and Either Obesity or Overweight Overview of Clinical Trial Study 1 (NCT03574597) was a multi-national, multi-center, placebo-controlled, double-blind trial to determine the effect of WEGOVY injection relative to placebo on major adverse CV events (MACE) when added to current standard of care, which included management of CV risk factors and individualized healthy lifestyle counseling (including diet and physical activity) in adults with established CV disease and either obesity or overweight
The injectable form tends to produce a steadier effect over time, though watery diarrhea and other gastrointestinal symptoms can still occur in either form
.png)
